SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001723128-24-000014
Filing Date
2024-03-14
Accepted
2024-03-14 17:04:14
Documents
165
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrx-20231231.htm   iXBRL 10-K 3450030
2 EX-4.2 amrx-2023123110xkex42xdesc.htm EX-4.2 21497
3 EX-21.1 amrx2023311210-kexx211.htm EX-21.1 17355
4 EX-23.1 amrx-2023123110xkexx231.htm EX-23.1 5729
5 EX-31.1 amrx-2023123110xkexx311.htm EX-31.1 10716
6 EX-31.2 amrx-2023123110xkexx312.htm EX-31.2 10702
7 EX-31.3 amrx-2023123110xkexx313.htm EX-31.3 10770
8 EX-32.1 amrx-2023123110xkexx321.htm EX-32.1 5719
9 EX-32.2 amrx-2023123110xkexx322.htm EX-32.2 5646
10 EX-32.3 amrx-2023123110xkexx323.htm EX-32.3 5829
11 EX-97.1 amrx-2023123110xkexx971xcl.htm EX-97.1 24212
17 amrx-20231231_g1.jpg GRAPHIC 243019
  Complete submission text file 0001723128-24-000014.txt   19517797

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20231231.xsd EX-101.SCH 154059
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20231231_cal.xml EX-101.CAL 147698
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20231231_def.xml EX-101.DEF 802340
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20231231_lab.xml EX-101.LAB 1339316
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20231231_pre.xml EX-101.PRE 1108308
167 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20231231_htm.xml XML 3269214
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38485 | Film No.: 24751168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)